What happens to muscles in fibromyalgia syndrome
The main somatic symptoms of fibromyalgia syndrome (FMS) are chronic musculoskeletal pain, stiffness, and fatigue, all of which are related to the muscle system and its functioning.
The aim of this study was to evaluate whether the asymptomatic upper and lower extremity muscles evaluated using ultrasonography (US) were different from healthy controls in both newly diagnosed and established FMS and to assess whether muscle measurements were related to fatigue and disease severity, as well as quality of life.
This study was conducted on 152 subjects (102 patients and 50 healthy controls) as a cross-sectional controlled trial. Real-time imaging of cross-sectional thickness (CST) (for deltoid, biceps brachii, triceps brachii, forearm flexor, tibialis anterior, and gastrocnemius medialis), and cross-sectional areas (CSAs) (quadriceps femoris (QF)) measurements were performed using US. Fatigue and disease severity as well as quality of life scales were given to all participants.
In both patient groups, decreased QF muscle CSA was significantly correlated with increased fatigue severity and decreased overall quality of life and energy levels. Moreover, in patients with established disease, there was a significant correlation between the decrease in QF muscle CSA and increased social isolation and between the decrease in biceps brachii muscle CST and increased fatigue severity.
Whether in newly diagnosed or established disease, muscle measurement values and quality of life parameters were significantly decreased in patients with FMS compared with healthy controls.
KeywordsFatigue Fibromyalgia syndrome Quadriceps femoris Quality of life Ultrasound
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
The study protocol was approved by the local ethics committee, and it was carried out in accordance with the Declaration of Helsinki. Each participant’s caregiver was informed about the purpose of the study before participation, and the completion of the studies was voluntary.
- 1.Morin AK (2009) Fibromyalgia: a review of management options. Formulary 44:362–373Google Scholar
- 7.Pernambuco AP, Schetino LP, Viana RS, Carvalho LS, d’Avila Reis D (2015) The involvement of melatonin in the clinical status of patients with fibromyalgia syndrome. Clin Exp Rheumatol 33:14–19Google Scholar
- 18.Akyol Y, Ulus Y, Tander B, Bilgici A, Kuru O (2013) Muscle strength, fatigue, functional capacity, and proprioceptive acuity in patients with fibromyalgia. Turk J Phys Med Rehab 59:292–298Google Scholar
- 28.Brosseau L, Wells GA, Tugwell P, Egan M, Wilson KG, Dubouloz CJ, Casimiro L, Robinson VA, McGowan J, Busch A, Poitras S, Moldofsky H, Harth M, Finestone HM, Nielson W, Haines-Wangda A, Russell-Doreleyers M, Lambert K, Marshall AD, Veilleux L, Ottawa Panel Members (2008) Ottowa panel evidence-based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: part 1. Phys Ther 88:857–871CrossRefGoogle Scholar
- 38.Hairi NN, Cumming RG, Naganathan V, Handelsman DJ, le Couteur DG, Creasey H, Waite LM, Seibel MJ, Sambrook PN (2010) Loss of muscle strength, mass (sarcopenia), and quality (specific force) and its relationship with functional limitation and physical disability: the concord health and ageing in men project. J Am Geriatr Soc 58:2055–2062CrossRefGoogle Scholar